Lipid Peroxidation Is Not Increased in Patients With Untreated Mild-to-Moderate Hypertension
- 1 February 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 41 (2) , 286-288
- https://doi.org/10.1161/01.hyp.0000050963.16405.e6
Abstract
In contrast with the huge amount of experimental data available, only few and somewhat unconvincing clinical studies support the hypothesis that oxidative stress is involved in the early stages of ...Keywords
This publication has 9 references indexed in Scilit:
- Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implicationsTrends in Pharmacological Sciences, 2002
- Increased urinary F2-isoprostanes in systemic sclerosis, but not in primary Raynaud's phenomenon: Effect of cold exposureArthritis & Rheumatism, 2002
- Determination of isoprostaglandin F2α type III in human urine by gas chromatography–electronic impact mass spectrometry. Comparison with enzyme immunoassayJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Oxidative stress and vascular damage in hypertensionCurrent Opinion in Nephrology and Hypertension, 2001
- Measurement of F2-isoprostanes as an index of oxidative stress in vivoFree Radical Biology & Medicine, 2000
- Relationships between cardiovascular remodelling and the pulse pressure in never treated hypertensionJournal of Human Hypertension, 2000
- CAROTID REMODELING IN ESSENTIAL HYPERTENSION: ROLE OF BLOOD PRESSURE, INDEXED PARAMETERS, AND ASSOCIATION WITH CARDIAC MASS AND AORTIC STIFFNESSClinical and Experimental Hypertension, 2000
- Measurement of Lipid PeroxidationFree Radical Research, 1998
- Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative DamageNew England Journal of Medicine, 1995